APA Zitierstil

Naik, M., Kapur, M., Gupta, V., Sethi, H., & Srivastava, K. (2021). Ripasudil Endgame: Role of Rho-Kinase Inhibitor as a Last-Ditch-Stand Towards Maximally Tolerated Medical Therapy to a Patient of Advanced Glaucoma. Clin Ophthalmol.

Chicago Zitierstil

Naik, Mayuresh, Monika Kapur, VishnuSwarup Gupta, HarinderSingh Sethi, und Kartikeya Srivastava. "Ripasudil Endgame: Role of Rho-Kinase Inhibitor As a Last-Ditch-Stand Towards Maximally Tolerated Medical Therapy to a Patient of Advanced Glaucoma." Clin Ophthalmol 2021.

MLA Zitierstil

Naik, Mayuresh, et al. "Ripasudil Endgame: Role of Rho-Kinase Inhibitor As a Last-Ditch-Stand Towards Maximally Tolerated Medical Therapy to a Patient of Advanced Glaucoma." Clin Ophthalmol 2021.

Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.